Company Category: Research

CH Kilger, Patent & Trademark Attorneys

An International Approach With its head office in Berlin, branch offices in Munich and Buenos Aires CH KILGER offers a truly international approach providing a global IP service to its clients. The Munich office serves also for the preparation of the frequent oral proceedings CH KILGER takes part in. In Buenos Aires CH KILGER coordinates its Latin America services. The patent attorneys are highly specialized and strategic in their approach. A Wingspan of Expertise CH KILGER provides IP services ranging from trademark and patent prosecution, patent infringement and litigation, due diligence work, freedom-to-operate analyses, to opinion work and IP-sales/licensing transactions. CH KILGER can assist you in all technical areas such as the chemical, electrical, nanotechnology, food, biotechnology and pharmaceutical or the engineering fields. Strong scientific backgrounds, as well as years of legal experience working with the European Patent Office, the Latin American patent offices, top-tier international law firms and in-house counsel, mean the CH KILGER lawyers understand their technical, business, and legal goals. Our interdisciplinary approach leads to best possible synergies for our clients. Our Clients and Colleagues CH KILGER represents an international clientele of inventors as well as investors working with the most recent high-tech technologies. The clients range from multinational pharmaceutical corporations to start ups in various fields such as nanotechnology, microfluidics, polymer chemistry and biotechnology. Clients and colleagues have praised the firm for its exquisite work.

Read More

CGI

Founded in 1976, CGI is among the largest IT and business consulting services firms in the world. We are insights-driven and outcomes-focused to help accelerate returns on your investments. Across 21 industry sectors and 400 locations worldwide, we provide comprehensive, scalable and sustainable IT and business consulting services that are informed globally and delivered locally. We help retail, consumer and services organizations use AI and data-driven approaches to increase profitability by delivering friction-free omnichannel customer experiences, improving supply chain agility, streamlining store operations, embracing sustainable transformation and optimizing IT spend. | Founded in 1976, CGI is among the largest IT and business consulting services firms in the world. We are insights-driven and outcomes-based to help accelerate returns on your investments. In the Life Sciences industry, we have more than 6,000 experts across the globe helping clients transform their business processes and digital platforms. As the industry continues to evolve rapidly to adapt to changing market demands, our expertise and services help life sciences organizations increase speed, efficiency, and innovation, while keeping pace with compliance demands. CGI helps clients increase efficiency, accuracy, and safety; enhance decision-making through access to real-time data for optimal production operations; launch new therapies for cancer and rare diseases; and drive digital transformation across their research & development, manufacturing and commercial functions globally; and ultimately, bringing life-changing therapies to patients faster! CGI delivers clinical and IT solutions for 11 of the top 20 global biotech and pharmaceutical companies, including helping these organizations optimize their processes; enabling improved production processes by combining end-to-end services including consulting, implementation, and managed services and with Manufacturing Execution System Our expertise is spread across R&D, clinical operations, quality and regulatory information management (RIM), laboratory operations, manufacturing, commercial, and transformation consulting. CGI provides life science subject matter expertise across the value chain to both small and large pharmaceutical corporations. Our teams are comprised of subject-matter experts with deep knowledge of all industry-specific requirements, such as regulatory (FDA, HC, EMA), quality assurance (GxP), and validation (CSV-GAMPV) guidelines. | Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 94,000 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2024 reported revenue is CA$14.68 billion and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at cgi.com. | CGI Inc. is known as a world-class gear and precision component manufacturer that also offers design and manufacturing of motion control subassemblies. The company’s facility is fully certified to ISO 9001, ISO 13485, and AS/EN9100. CGI thrives on customer-driven innovation. It acts as its clients’ design and manufacturing partner, helping to differentiate their product, machine, or innovation. | With more than five decades of direct experience, we understand the payments industry. Financial institutions around the world are increasingly relying on CGI to help them navigate the coming tides of open banking, make the jump to real-time, mitigate evolving security threats and meet impending regulatory deadlines to prepare for a digital-first future. | From Prototype to Production CGI Motion enables design excellence across a wide range of industrial applications. We thrive on customer driven innovation in precision gearbox, precision machined components and electro-mechanical assembly solutions ranging from aerospace systems to semiconductor applications. We are your design and manufacturing partner helping to differentiate your product, machine or innovation. Our team of problem solving engineers and product managers can bring your application to market on time and under budget. Whether it’s an improvement on a current design or groundbreaking new designs, CGI has the know-how and team to enable design excellence. | CGI is among the largest IT and business consulting services firms in the world. We are an IT Systems Integrator working to advise, build and operate bespoke, technically complex, mission-critical information systems. Bringing innovation to our clients using proven and emerging technologies, agile delivery processes and our expertise across space, defence, intelligence, aerospace and maritime and end-to-end cyber capability. | Founded in 1976, CGI is one of the world’s largest independent IT and business consulting firms. With 94,000 professionals, CGI delivers end-to-end services—from strategic consulting and systems integration to managed IT, business process, and IP solutions. Through a local relationship model and global delivery network, CGI drives clients’ digital transformation. Fiscal 2025 revenue: CA$15.91B. Learn more at cgi.com.

Read More

Certara

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include nearly 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. | Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.

Read More

Ceragem Co., Ltd.

Founded in 1998, CERAGEM is the global home wellness solution provider within more than 70 countries. With the philosophy of health care management begins at home, we provide innovative wellness products and services for your everyday. We bring health to your home and build healthy habits to shape your fulfilling life.

Read More

Centre for Virology, Vaccinology and Therapeutics

The Centre for Virology, Vaccinology, and Therapeutics (CVVT), established in 2020 with the University of Hong Kong, is dedicated to reducing the health and economic impacts of future outbreaks. By pioneering rapid diagnostics, potent antimicrobials, and advanced vaccines, CVVT tackles endemic diseases in peacetime and prepares the world for epidemics and pandemics. Serving as a crucial bridge between foundational research and transformative technologies, CVVT cultivates a dynamic startup ecosystem focused on innovative solutions for infectious diseases and global health advancements. At this exhibition, discover our innovative startups: • Orimmune BioTech Limited, introducing its revolutionary Δ42PD1-specific antibody drug, set to redefine cancer immunotherapy with a novel immune-modulatory approach. • Antenovus Biotechnology Limited, combating antimicrobial resistance (AMR) with antivirulence therapies and antibiotic adjuvants targeting pathogens like MRSA. • Hong Kong Universal Vaccine Limited, unveiling its next-generation inhaled powder vaccine for children and elderly, offering needle-free mucosal immunity against influenza, COVID, and RSV. • BiomOrgan Limited, showcasing the world’s first human respiratory organoid culture system, transforming drug development and virus research. Visit our booth to explore how CVVT converts visionary research into practical solutions, enhancing global health resilience and positioning Hong Kong as a biotechnology hub against emerging infectious threats.

Read More

Centre for Translational Stem Cell Biology

Centre for Translational Stem Cell Biology (CTSCB) provides Hong Kong with an opportunity to excel in scientific and medical research. A team of top-notch scientists and clinicians from the University of Hong Kong and the University of Cambridge collaborates to elevate stem cell technology to new heights. By leveraging a pioneering patented technology, Expanded Potential Stem Cells (EPSCs), CTSCB is dedicated to advancing fundamental research and translating discoveries into regenerative medicine, organ transplantation and genomic medicine for the benefit of people worldwide. CTSCB primarily focuses on producing mature and functional cells for regenerative medicine with the patented technology, enabling in-depth study of immune disease mechanism, and expediting the development of antiviral, anti-ageing natural products and antibody drugs. Our vision is to translate medical discoveries and homegrown technologies into applications that not only serve medical and biotechnological purposes but also extend to the agricultural sector, fostering the growth of innovation and technology. | Imagine a future where healthcare is transformed by cutting-edge stem cell technology. Centre for Translational Stem Cell Biology (CTSCB), a collaboration between the University of Hong Kong and the University of Cambridge, supported by the Innovation and Technology Commission, is at the forefront of making this vision a reality. Leveraging patented Expanded Potential Stem Cell (EPSC) technology, we can create any cell type, both embryonic and extra-embryonic, offering immense potential for regenerative medicine and therapeutic applications. Our research focuses on intelligent drug screening, precision medicine and cell-based therapies. We develop next-generation stem cell technology that improves patient outcomes and enhances quality of life. Our drug screening platforms support pharmaceutical and health supplement companies in streamlining their development processes using multicellular organoid systems and personalized disease modelling. We also explore health and cosmetic products derived from EPSC technology, with interests in product co-development to address various health issues. By attracting top global talent and fostering innovation, CTSCB is well-positioned to enhance therapeutic applications and promote longevity. Through our innovative research and commitment to excellence, CTSCB aims to lead the way in revolutionary healthcare solutions for generations to come.

Read More

Center for Natural Product Systems Biology

The Center for Natural Product Systems Biology advances research through big data and AI to enhance R&D capabilities in natural product technologies. We study natural product-microbiome interactions by generating integrated omics data including compound, genomic, proteomic, transcriptomic, and metabolomic analyses.

Read More

Center for Electrochemical Energy Storage

The Center for Electrochemical Energy Storage | Ulm & Karlsruhe (CELEST) provides a broad platform for scientific collaboration, (science) communication, qualification of students’ and technology transfer in the field of electrochemical energy storage (EES) ranging from fundamental research to application as well as sustainability issues. Research fields of CELEST members include Li-, post-Li-batteries and alternative electrochemical energy storage conversion systems. The Cluster of Excellence POLiS (Post Lithium Storage) is one of CELEST‘s main activities in the post-lithium area: The focus is on sustainable alternatives based on sodium, potassium, magnesium, calcium, aluminium and chloride ions.

Read More

CEMTEC Inc.

CEMTEC is a world-renowned specialist for dry and wet grinding technologies for many kinds of bulk materials, stones/earth, and ores. We offer systems for grinding different materials, including mineral bulk material, as well as rotary drums for thermal (burning, drying, cooling) and mechanical treatment (mixing, washing, conditioning) of various bulk materials. CEMTEC provides turnkey projects as well as single machines.

Read More